Subscribe to our Facebook Bot
US FDA Grants Priority Review for Daratumumab in Front Line Multiple Myeloma
In August 2012, Genmab granted Janssen Biotech, Inc. an exclusive worldwide license to develop, manufacture and commercialize daratumumab. ?The granting of priority review to the submission of daratumumab in front line multiple myeloma is an important ...
Join over 5000 Subscribers!
Get latest News, Widgets, Apps and much more straight into your INBOX for free. Just Enter your email address, Verify and join our Newsletter!